Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Susanna Medellín-Garibay"'
Autor:
Ana S Rodríguez-Báez, Arturo Ortiz-Álvarez, Melissa Romano-Aguilar, Fidel Martínez-Gutiérrez, Silvia Romano-Moreno, Rosa C Milán-Segovia, Susanna Medellín-Garibay
Publikováno v:
Open Forum Infectious Diseases. 9
Background Piperacillin-Tazobactam (PIP/TAZ) is a combination of a β-lactam antibiotic with a β-lactamase inhibitor, used to treat moderate to severe infections due to its broad-spectrum antibacterial activity. Its bactericidal effect is time-depen
Autor:
Luz A Espiricueta-Zavala, Diego Sanchez-Durán, Arturo Ortiz-Álvarez, Ana P Huerta-García, Cristian J Rodríguez-Pinal, Rosa C Milán-Segovia, Silvia Romano-Moreno, Susanna Medellín-Garibay
Publikováno v:
Open Forum Infectious Diseases. 9
Background Directly Observed Treatment Short Course for Tuberculosis (TB) (DOTS) treatment currently produces a cure rate of 80%. Rifampicin (RMP) and isoniazid (INH) are the main bactericides; both show wide inter-individual pharmacokinetics and nar
Autor:
Melissa Romano-Aguilar, Arturo Ortiz-Álvarez, Susanna Medellín-Garibay, Fidel Martínez-Gutiérrez, Helgi Jung-Cook, Rosa C Milán-Segovia, Silvia Romano-Moreno
Publikováno v:
Open Forum Infectious Diseases. 9
Background Meropenem (MRP) is commonly used to treat serious infections and displays wide variability in plasma concentrations after administration of the same dose in critically ill patients due to factors that affect MRP volume of distribution (V)
Publikováno v:
Open Forum Infectious Diseases. 2022 Supplement, Vol. 9, pS1-S936. 2220p.
Autor:
Rodríguez‐Aguilar, Maribel, Ramírez‐García, Sofía, Ilizaliturri‐Hernández, Cesar, Gómez‐Gómez, Alejandro, Van‐Brussel, Evelyn, Díaz‐Barriga, Fernando, Medellín‐Garibay, Susanna, Flores‐Ramírez, Rogelio
Publikováno v:
Biomedical Chromatography; Dec2019, Vol. 33 Issue 12, pN.PAG-N.PAG, 1p